- Location: Hotel Russell, London
- Date: Thursday 30th April 2015
- Price: £288.00
Featuring two case studies of recent big pharma deals, we will hear from those involved in both of the deals. Catherine Pickering from Merck Serono will provide an insight into their Global Strategic Alliance with Pfizer, to be followed by details of the GSK / Novartis asset swap deal from Subesh Williams at GlaxoSmithKline.
The second half of the meeting will have an educational focus as we are given a demonstration of the new UKTI database developed by the UKTI Life Sciences Organisation and the Office for Life Sciences. To finish we will be given a brief overview on the key aspects of Health Economics and Economic Evaluation from Market Access specialists at Roboleo & Co.
Following feedback from the recent member survey, we have changed the format of this meeting to a one day event, starting with a netowrking lunch and finishing with dinner. Discounted rates for those requiring accommodation are available.
|1.30pm - 2.30pm||Registration
Lunch in Tempus Restaurant
|2.30pm - 3.15pm||Case Study: Merck Serono & Pfizer Global Strategic Alliance
Head of Oncology Licensing, Global Business Development, Merck Serono
|3.15pm - 4.00pm||Case Study: GSK / Novartis Asset Swap Deal
SVP Global Corporate Development, GlaxoSmithKline
|4.00pm - 4.30pm||Break|
|4.30pm - 5.15pm||UKTI Database Demonstration
Marketing Specialist, UKTI Life Sciences Organisation (LSO)
|5.15pm - 6.00pm||Economic Evaluation in Acquisition and Licensing
Roboleo & Co
|6.00pm - 7.30pm||Networking Drinks Reception|
|7.30pm - 10.30pm||Dinner|
1-8 Russell Square
You must be logged in to access the downloads.